Impact of COVID‐19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID‐19 patients with acute ischemic stroke

Resistance to fibrinolysis, levels of procoagulant/antifibrinolytic neutrophil extracellular traps (NETs), and the severity of acute ischemic stroke (AIS) are increased by COVID‐19. Whether NETs are components of AIS thrombi from COVID‐19 patients and whether COVID‐19 impacts the susceptibility of these thrombi to thrombolytic treatments remain unknown, however.

[1]  Maximo J Marin,et al.  Role of von Willebrand Factor in COVID-19 Associated Coagulopathy , 2021, The journal of applied laboratory medicine.

[2]  F. Szlam,et al.  COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography , 2021, Journal of Thrombosis and Thrombolysis.

[3]  D. Dwivedi,et al.  Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study , 2021, Journal of Thrombosis and Haemostasis.

[4]  R. Ariëns,et al.  Mechanisms of thrombosis and cardiovascular complications in COVID-19 , 2021, Thrombosis Research.

[5]  D. Lawrence,et al.  Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients , 2021, Scientific Reports.

[6]  Paloma Martin,et al.  Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction. , 2020, JAMA cardiology.

[7]  G. Lippi,et al.  ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID‐19: Evidence of SARS‐CoV‐2 induced secondary thrombotic microangiopathy , 2020, International journal of laboratory hematology.

[8]  Robert A. Campbell,et al.  Is there a role for the ACE2 receptor in SARS‐CoV‐2 interactions with platelets? , 2020, Journal of Thrombosis and Haemostasis.

[9]  L. Khalki,et al.  Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19 , 2020, Circulation research.

[10]  J. Desilles,et al.  Early Brain Imaging Shows Increased Severity of Acute Ischemic Strokes With Large Vessel Occlusion in COVID-19 Patients , 2020, Stroke.

[11]  J. Desilles,et al.  DNA Content in Ischemic Stroke Thrombi Can Help Identify Cardioembolic Strokes Among Strokes of Undetermined Cause , 2020, Stroke.

[12]  M. Rudelius,et al.  Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy , 2020, Circulation.

[13]  Sharon J Peacock,et al.  Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.

[14]  E. de Raucourt,et al.  Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy , 2020, Thrombosis and Haemostasis.

[15]  J. Desilles,et al.  Treatment of Acute Ischemic Stroke due to Large Vessel Occlusion With COVID-19 , 2020, Stroke.

[16]  D. Alsteens,et al.  Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor , 2020, Nature Communications.

[17]  S. Kremer,et al.  Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.

[18]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[19]  F. Meziani,et al.  DNA‐bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  J. Olivot,et al.  Acute ischemic stroke thrombi have an outer shell that impairs fibrinolysis , 2019, Neurology.

[21]  L. Desender,et al.  Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance , 2019, Haematologica.

[22]  J. Desilles,et al.  Thrombolysis-resistant intracranial clot , 2018, Neurology.

[23]  J. Michel,et al.  Downstream Microvascular Thrombosis in Cortical Venules Is an Early Response to Proximal Cerebral Arterial Occlusion , 2018, Journal of the American Heart Association.

[24]  J. Michel,et al.  Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke , 2018, Stroke.

[25]  L. Desender,et al.  Neutrophil extracellular traps in ischemic stroke thrombi , 2017, Annals of neurology.

[26]  George Y. Liu,et al.  Angiotensin-converting enzyme enhances the oxidative response and bactericidal activity of neutrophils. , 2017, Blood.

[27]  J. Montaner,et al.  Increased von Willebrand factor, P-selectin and fibrin content in occlusive thrombus resistant to lytic therapy , 2016, Thrombosis and Haemostasis.

[28]  R. Marchi,et al.  Effect of von Willebrand factor on clot structure and lysis , 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[29]  K. Preissner,et al.  Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size. , 2015, Circulation research.

[30]  M. Krumrey,et al.  Mechanical Stability and Fibrinolytic Resistance of Clots Containing Fibrin, DNA, and Histones* , 2013, The Journal of Biological Chemistry.

[31]  A. Wolberg,et al.  Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. , 2011, Blood.

[32]  K. Kolev,et al.  Proteolytic resistance conferred to fibrinogen by von Willebrand factor , 2009, Thrombosis and Haemostasis.